Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence, Risk Factors, and Temporal Trends of Tongue Cancer: A Population-Based Study.

Cancer medicine·2026
Same author

Cochlear device explantation in patients with nasopharyngeal cancer irradiation.

Cochlear implants international·2025
Same author

Incidence, Risk Factors, and Epidemiological Trends of Head and Neck Cancer: A Global Analysis.

MedComm·2025
Same author

A Quasi-Experimental Study on Feeding Behaviors and Related Outcomes by Provision of Molded Puree in Aged-Care Facilities.

Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP)·2025
Same author

Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.

JAMA oncology·2025

Related Experiment Video

Updated: Mar 18, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K

Low-grade myofibroblastic sarcoma: A population-based study.

Jason Y K Chan1, Zhen Gooi2, Eddy W Y Wong1

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.

The Laryngoscope
|July 6, 2016
PubMed
Summary
This summary is machine-generated.

Low-grade myofibroblastic sarcoma (LGMS) is rare, most frequently affecting extremities, not the head and neck as previously thought. Older age is linked to poorer survival in LGMS patients.

Keywords:
Low-grade myofibroblastic sarcomamyofibroblastic sarcoma

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.8K

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Low-grade myofibroblastic sarcoma (LGMS) is a rare tumor.
  • LGMS has been described as having a predilection for the head and neck region.
  • Limited data exists on the demographics and survival of LGMS in the United States.

Purpose of the Study:

  • To analyze the demographics, clinic-pathologic features, and survival characteristics of LGMS.
  • To investigate the primary sites of LGMS occurrence.
  • To identify prognostic factors for LGMS survival.

Main Methods:

  • Retrospective analysis of a LGMS cohort from the Surveillance, Epidemiology, and End Results (SEER) Program database.
  • Data collected for cases diagnosed between 2001 and 2012.
  • Multivariate analysis was performed to assess survival predictors.

Main Results:

  • A total of 49 LGMS cases were identified.
  • The 5-year overall survival was 71.6%, and disease-specific survival was 76.3%.
  • Extremities were the most common primary site (40.8%), followed by the head and neck (26.5%). Older age was significantly associated with worse survival (P < .05).

Conclusions:

  • LGMS is uncommon in the US, with a higher incidence in the extremities than previously reported for the head and neck region.
  • Current treatment primarily involves surgery, but optimal extent and the role of radiotherapy require further investigation.
  • This study provides valuable insights into LGMS epidemiology and survival.